Brief: Nanobiotix To Be Able To Fund Operations Into Q3 2025
22/05/2024 07:58
May 22 (Reuters) - Nanobiotix SA NANOB.PA :
* ANTICIPATES THAT CASH AND CASH EQUIVALENTS OF EUR 58.9 MLN
AS OF
MARCH 31 2024 WILL FUND ITS OPERATIONS INTO Q3 2025
Source text for Workspace: ID:nGNX5D99WJ
Further company coverage: NANOB.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48587696600;))
Recent news on Nanobiotix SA
See all newsBrief: Nanobiotix S.A. H1 Net Income EUR -34.3 Million
France's Nanobiotix H1 net loss widens on lower revenue, absence of 2025 one-off gain
Brief: Nanobiotix Reports Encouraging Full Phase 1 Results For Lung Cancer Drug JNJ-1900
Brief: Nanobiotix Q1 Cash And Cash Equivalents Of €42.1 Mln
Brief: NANOBIOTIX Announces Closing Of Global Offering